Incidental Mutation 'IGL03098:Efnb2'
ID |
452976 |
Institutional Source |
Beutler Lab
|
Gene Symbol |
Efnb2
|
Ensembl Gene |
ENSMUSG00000001300 |
Gene Name |
ephrin B2 |
Synonyms |
Eplg5, Epl5, Lerk5, Htk-L, NLERK-1, LERK-5, ELF-2 |
Accession Numbers |
|
Essential gene? |
Essential
(E-score: 1.000)
|
Stock # |
IGL03098 (G1)
|
Quality Score |
225 |
Status
|
Validated
|
Chromosome |
8 |
Chromosomal Location |
8667434-8711242 bp(-) (GRCm39) |
Type of Mutation |
unclassified |
DNA Base Change (assembly) |
A to T
at 8713420 bp (GRCm39)
|
Zygosity |
Heterozygous |
Amino Acid Change |
|
Ref Sequence |
ENSEMBL: ENSMUSP00000146939
(fasta)
|
Gene Model |
predicted gene model for transcript(s):
[ENSMUST00000001319]
[ENSMUST00000048545]
[ENSMUST00000207817]
|
AlphaFold |
P52800 |
Predicted Effect |
probably benign
Transcript: ENSMUST00000001319
|
SMART Domains |
Protein: ENSMUSP00000001319 Gene: ENSMUSG00000001300
Domain | Start | End | E-Value | Type |
Pfam:Ephrin
|
32 |
167 |
4.6e-53 |
PFAM |
transmembrane domain
|
231 |
253 |
N/A |
INTRINSIC |
low complexity region
|
267 |
277 |
N/A |
INTRINSIC |
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000048545
|
SMART Domains |
Protein: ENSMUSP00000039493 Gene: ENSMUSG00000040459
Domain | Start | End | E-Value | Type |
low complexity region
|
3 |
75 |
N/A |
INTRINSIC |
low complexity region
|
95 |
113 |
N/A |
INTRINSIC |
Pfam:ARGLU
|
117 |
267 |
8.2e-55 |
PFAM |
|
Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000048606
|
Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000207070
|
Predicted Effect |
probably benign
Transcript: ENSMUST00000207817
|
Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000208252
|
Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000209169
|
Meta Mutation Damage Score |
0.0898 |
Coding Region Coverage |
- 1x: 0.0%
- 3x: 0.0%
- 10x: 0.0%
- 20x: 0.0%
|
Validation Efficiency |
92% (44/48) |
MGI Phenotype |
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the ephrin (EPH) family. The ephrins and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, especially in the nervous system and in erythropoiesis. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. This gene encodes an EFNB class ephrin which binds to the EPHB4 and EPHA3 receptors. [provided by RefSeq, Jul 2008] PHENOTYPE: Homozygotes for targeted null mutations exhibit defects in angiogenesis of both arteries and veins and die by embryonic day 11.5. [provided by MGI curators]
|
Allele List at MGI |
|
Other mutations in this stock |
Total: 42 list
Gene | Ref | Var | Chr/Loc | Mutation | Predicted Effect | Zygosity |
4933416I08Rik |
TCC |
TCCC |
X: 52,692,862 (GRCm39) |
|
noncoding transcript |
Het |
Abca15 |
T |
C |
7: 119,987,499 (GRCm39) |
|
probably null |
Het |
Adcy4 |
T |
C |
14: 56,019,038 (GRCm39) |
Q173R |
probably null |
Het |
Arhgef19 |
A |
G |
4: 140,974,879 (GRCm39) |
D113G |
possibly damaging |
Het |
Btbd6 |
A |
G |
12: 112,942,038 (GRCm39) |
E501G |
probably damaging |
Het |
Btnl2 |
T |
C |
17: 34,584,190 (GRCm39) |
V371A |
probably benign |
Het |
Cd84 |
G |
T |
1: 171,700,267 (GRCm39) |
R128L |
possibly damaging |
Het |
Cilp |
TGGG |
TGG |
9: 65,187,412 (GRCm39) |
|
probably null |
Het |
Crb1 |
CG |
C |
1: 139,164,824 (GRCm39) |
|
probably null |
Het |
Dsg3 |
A |
T |
18: 20,643,422 (GRCm39) |
|
probably benign |
Het |
Fam24b |
T |
C |
7: 130,927,977 (GRCm39) |
S71G |
probably benign |
Het |
Flacc1 |
G |
T |
1: 58,730,908 (GRCm39) |
H49Q |
probably benign |
Het |
Hgd |
G |
A |
16: 37,436,607 (GRCm39) |
C180Y |
probably benign |
Het |
Hjurp |
TGGG |
TTGCGGG |
1: 88,194,002 (GRCm39) |
|
probably benign |
Het |
Hsd17b7 |
C |
T |
1: 169,780,649 (GRCm39) |
E320K |
probably damaging |
Het |
Kcmf1 |
A |
T |
6: 72,826,567 (GRCm39) |
M1K |
probably null |
Het |
Letm2 |
T |
A |
8: 26,071,745 (GRCm39) |
T386S |
possibly damaging |
Het |
Lvrn |
A |
T |
18: 47,014,477 (GRCm39) |
|
probably null |
Het |
Mmp1a |
TG |
TGG |
9: 7,465,083 (GRCm38) |
|
probably null |
Het |
Nid2 |
G |
A |
14: 19,856,006 (GRCm39) |
D1244N |
probably damaging |
Het |
Nvl |
G |
T |
1: 180,921,471 (GRCm39) |
Q843K |
probably benign |
Het |
Obi1 |
T |
C |
14: 104,716,253 (GRCm39) |
I707V |
possibly damaging |
Het |
Or1e30 |
T |
G |
11: 73,678,529 (GRCm39) |
I255S |
probably benign |
Het |
Pi4ka |
A |
T |
16: 17,143,891 (GRCm39) |
I726N |
probably damaging |
Het |
Rab25 |
A |
T |
3: 88,449,567 (GRCm39) |
C209S |
probably damaging |
Het |
Rgs6 |
A |
T |
12: 83,032,150 (GRCm39) |
I21F |
probably damaging |
Het |
Rnf10 |
T |
C |
5: 115,410,426 (GRCm39) |
D16G |
probably damaging |
Het |
Rnmt |
G |
A |
18: 68,439,073 (GRCm39) |
V61M |
probably damaging |
Het |
Rrs1 |
GCTC |
GC |
1: 9,616,328 (GRCm39) |
|
probably null |
Het |
Scd4 |
A |
T |
19: 44,321,931 (GRCm39) |
M1L |
possibly damaging |
Het |
Speer4c1 |
A |
C |
5: 15,919,214 (GRCm39) |
|
probably benign |
Het |
Sptb |
A |
G |
12: 76,668,273 (GRCm39) |
I608T |
probably damaging |
Het |
Sstr5 |
A |
G |
17: 25,710,251 (GRCm39) |
V326A |
probably benign |
Het |
Sugct |
T |
C |
13: 17,846,321 (GRCm39) |
D62G |
probably damaging |
Het |
Thada |
C |
G |
17: 84,641,569 (GRCm39) |
D1306H |
possibly damaging |
Het |
Thap1 |
C |
G |
8: 26,652,498 (GRCm39) |
P79A |
probably benign |
Het |
Tra2a |
G |
A |
6: 49,225,969 (GRCm39) |
S157L |
probably damaging |
Het |
Trappc10 |
C |
T |
10: 78,050,520 (GRCm39) |
R307Q |
probably damaging |
Het |
Trim9 |
A |
G |
12: 70,327,467 (GRCm39) |
I390T |
possibly damaging |
Het |
Usp24 |
T |
C |
4: 106,228,230 (GRCm39) |
V765A |
probably benign |
Het |
Wdr90 |
C |
A |
17: 26,078,961 (GRCm39) |
|
probably benign |
Het |
Ybey |
A |
T |
10: 76,304,078 (GRCm39) |
C41* |
probably null |
Het |
|
Other mutations in Efnb2 |
Allele | Source | Chr | Coord | Type | Predicted Effect | PPH Score |
IGL00089:Efnb2
|
APN |
8 |
8,710,589 (GRCm39) |
missense |
probably benign |
0.08 |
IGL02076:Efnb2
|
APN |
8 |
8,710,488 (GRCm39) |
missense |
probably benign |
|
IGL03333:Efnb2
|
APN |
8 |
8,689,275 (GRCm39) |
nonsense |
probably null |
|
R1416:Efnb2
|
UTSW |
8 |
8,672,329 (GRCm39) |
critical splice donor site |
probably null |
|
R1760:Efnb2
|
UTSW |
8 |
8,673,184 (GRCm39) |
missense |
possibly damaging |
0.90 |
R1783:Efnb2
|
UTSW |
8 |
8,673,237 (GRCm39) |
missense |
probably damaging |
1.00 |
R4272:Efnb2
|
UTSW |
8 |
8,670,698 (GRCm39) |
missense |
probably damaging |
0.99 |
R4398:Efnb2
|
UTSW |
8 |
8,670,832 (GRCm39) |
missense |
possibly damaging |
0.80 |
R4782:Efnb2
|
UTSW |
8 |
8,673,104 (GRCm39) |
splice site |
probably null |
|
R4799:Efnb2
|
UTSW |
8 |
8,673,104 (GRCm39) |
splice site |
probably null |
|
R5193:Efnb2
|
UTSW |
8 |
8,673,162 (GRCm39) |
missense |
probably damaging |
1.00 |
R5443:Efnb2
|
UTSW |
8 |
8,670,862 (GRCm39) |
missense |
probably damaging |
1.00 |
R5749:Efnb2
|
UTSW |
8 |
8,689,347 (GRCm39) |
missense |
probably damaging |
1.00 |
R6083:Efnb2
|
UTSW |
8 |
8,672,328 (GRCm39) |
splice site |
probably null |
|
R6266:Efnb2
|
UTSW |
8 |
8,710,524 (GRCm39) |
missense |
probably benign |
|
R6482:Efnb2
|
UTSW |
8 |
8,670,637 (GRCm39) |
missense |
probably damaging |
1.00 |
R7371:Efnb2
|
UTSW |
8 |
8,710,524 (GRCm39) |
missense |
probably benign |
|
R8813:Efnb2
|
UTSW |
8 |
8,670,731 (GRCm39) |
missense |
probably damaging |
1.00 |
R9630:Efnb2
|
UTSW |
8 |
8,670,617 (GRCm39) |
missense |
probably damaging |
1.00 |
Z1177:Efnb2
|
UTSW |
8 |
8,673,147 (GRCm39) |
critical splice donor site |
probably null |
|
|
Predicted Primers |
PCR Primer
(F):5'- TTACAGAGTGGCAGCAAAGC -3'
(R):5'- CAGTTACCTACTTGGATTTGCC -3'
Sequencing Primer
(F):5'- AGCAAAGCTGAAATTTCACAAAG -3'
(R):5'- CCTCACACAGGTTGTTGGG -3'
|
Posted On |
2017-01-24 |